Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

BACKGROUND: Diabetes is associated with a higher risk for adverse cardiovascular outcomes. To improve the health outcomes of patients with type 2 diabetes (T2DM), the American Diabetes Association (ADA) recommended target goals for the improvement of glycemic control and the reduction of cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Meloni, Alison R, DeYoung, Mary Beth, Han, Jenny, Best, Jennie H, Grimm, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622579/
https://www.ncbi.nlm.nih.gov/pubmed/23522121
http://dx.doi.org/10.1186/1475-2840-12-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622579/
https://www.ncbi.nlm.nih.gov/pubmed/23522121
http://dx.doi.org/10.1186/1475-2840-12-48

Ejemplares similares